H.R. 2500: Executive Appointee Ethics Improvement Act

Before you vote › Federal bills

H.R. 2500: Executive Appointee Ethics Improvement Act

115th Congress · introduced 2017-05-17 · Crime and Law Enforcement · Latest: Referred to the Subcommittee on the Constitution and Civil Justice.

federal

Save to my notebook What does this mean? Print

Official title

Executive Appointee Ethics Improvement Act

Plain summary

Executive Appointee Ethics Improvement Act This bill lengthens from one to two years the ban on certain senior personnel of the executive branch and independent agencies from lobbying the department or agency in which the person served. If the Director of the Office of Government Ethics decides to waive this restriction, such decision shall be published in the Federal Register unless it would compromise national security. The bill lengthens from two to five years the ban on certain very senior personnel of the executive branch and independent agencies, including the Vice President, from lobbying any office or employee of any department or agency in which such person served. Certain high-level employees of the executive branch are subject to a lifetime ban on knowingly representing a foreign entity before any officer or employee of any department or agency of the United States with the intent to influence a decision of such officer or employee. During a two-year period beginning on the date an individual is appointed to a covered position, such individual is banned from participating in any matter involving specific parties that is directly related to the individual's former employer or former clients. Additionally, any individual who was a registered lobbyist or who engaged in lobbying activities during a two-year period prior to appointment is prohibited from participating in any particular matter on which the individual made a lobbying contact or participating in the specific issue area in which the matter falls. The Office of Management and Budget (OMB) may waive these requirements if OMB certifies in writing to various congressional committees that it is in the public interest to grant the waiver.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

PSI Sci description of the legislative step (not an opinion).

The strongest published arguments

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Huffman, Jared [D-CA-2] · 8 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Bonnie Watson Coleman (D-NJ), Eleanor Holmes Norton (D-DC), Maxine Waters (D-CA), Jamie Raskin (D-MD), Mark DeSaulnier (D-CA)

Sponsor's campaign money: Rep. Huffman, Jared [D-CA-2] reported raising $1.2 million (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Sources

• Congressional Research Service summary (Introduced in House)
• Congress.gov
• Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-115hr2500.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/115/hr>

Record fed-us-cong115-hr2500 · catalog fed-us-congress-bills-cong115 · updated 2026-11-15 by psicol fed-bills-cong115